The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Advances in Oral Drug Delivery
Open accessAbstract
The oral route is the most common route for drug administration. It is the most preferred route, due to its advantages, such as non-invasiveness, patient compliance and convenience of drug administration. Various factors govern oral drug absorption including drug solubility, mucosal permeability, and stability in the gastrointestinal tract environment. Attempts to overcome these factors have focused on understanding the physicochemical, biochemical, metabolic and biological barriers which limit the overall drug bioavailability. Different pharmaceutical technologies and drug delivery systems including nanocarriers, micelles, cyclodextrins and lipid-based carriers have been explored to enhance oral drug absorption. To this end, this review will discuss the physiological, and pharmaceutical barriers influencing drug bioavailability for the oral route of administration, as well as the conventional and novel drug delivery strategies. The challenges and development aspects of pediatric formulations will also be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Cyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Block copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498
Zein: the industrial protein from corn
Shukla, R., & Cheryan, M. (2001) · Industrial Crops and Products · doi:10.1016/s0926-6690(00)00064-9 · Cited by 1,454
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Kulkarni, S. A., & Feng, S.-S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0958-3 · Cited by 768
Polymeric micelles as new drug carriers
Kwon, G. S., & Okano, T. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00401-2 · Cited by 710
Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures
Jouyban, A. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3pp4k · Cited by 669
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Physicochemical Profiling (Solubility, Permeability and Charge State)
Avdeef, A. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395100 · Cited by 587
The impact of medication regimen factors on adherence to chronic treatment: a review of literature
Ingersoll, K. S., & Cohen, J. (2008) · Journal of Behavioral Medicine · doi:10.1007/s10865-007-9147-y · Cited by 583
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Natural biodegradable polymers based nano-formulations for drug delivery: A review
George, A., Shah, P. A., & Shrivastav, P. S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.011 · Cited by 548
Bioadhesive microspheres as a controlled drug delivery system
Vasir, J. K., Tambwekar, K., & Garg, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00087-5 · Cited by 524
Cyclodextrin-based controlled drug release system
Hirayama, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00058-1 · Cited by 494
Physiological Parameters for Oral Delivery and in Vitro Testing
Mudie, D. M., Amidon, G. L., & Amidon, G. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100149j · Cited by 490
The high price of anticancer drugs: origins, implications, barriers, solutions
Prasad, V., De Jesús, K., & Mailankody, S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.31 · Cited by 442
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438
Custodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
Surfactant systems: their use in drug delivery
Lawrence, M. J. (1994) · Chemical Society Reviews · doi:10.1039/cs9942300417 · Cited by 401
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Pharmacological Strategies for Overcoming Multidrug Resistance
Nobili, S., Landini, I., Giglioni, B., & Mini, E. (2006) · Current Drug Targets · doi:10.2174/138945006777709593 · Cited by 393
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 392
Takahashi, M., Uechi, S., Takara, K., Asikin, Y., & Wada, K. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9013923 · Cited by 391
The barrier function of CYP3A4 and P-glycoprotein in the small bowel
Watkins, P. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00041-0 · Cited by 391
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120030422 · Cited by 387
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Microspheres of corn protein, zein, for an ivermectin drug delivery system
Liu, X., Sun, Q., Wang, H., Zhang, L., & Wang, J.-Y. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.02.013 · Cited by 363
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Expression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
Cerreia Vioglio, P., Chierotti, M. R., & Gobetto, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.001 · Cited by 350
Drug Interactions with Grapefruit Juice
Ameer, B., & Weintraub, R. A. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733020-00003 · Cited by 348
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Lee, M.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030264 · Cited by 335
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
Thummel, K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00039-2 · Cited by 318
Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin
Zhang, Y., Wei, W., Lv, P., Wang, L., & Ma, G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.016 · Cited by 315
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2012) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
Intestinal permeability and its relevance for absorption and elimination
Lennernäs, H. (2007) · Xenobiotica · doi:10.1080/00498250701704819 · Cited by 304
Read, N. W., Miles, C. A., Fisher, D., Holgate, A. M., Kime, N. D., Mitchell, M. A., Reeve, A. M., Roche, T. B., & Walker, M. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90925-7 · Cited by 292
Gastrointestinal absorption of drugs: methods and studies
Barthe, L., Woodley, J., & Houin, G. (1999) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00334.x · Cited by 290
Encapsulation of Essential Oils in Zein Nanospherical Particles
Parris, N., Cooke, P. H., & Hicks, K. B. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf040492p · Cited by 286
Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting
Lai, L. F., & Guo, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.025 · Cited by 281
Dong, J., Sun, Q., & Wang, J.-Y. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.084 · Cited by 272
Dahlgren, D., & Lennernäs, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080411 · Cited by 255
Gastric retention properties of superporous hydrogel composites
Chen, J., Blevins, W. E., Park, H., & Park, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00139-x · Cited by 251
Nanotechnology in Drug Delivery
(2009) · Springer eBooks · doi:10.1007/978-0-387-77667-5 · Cited by 247
Pang, K. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1507 · Cited by 245
Water-Insoluble Drug Formulation
(2008) · CRC Press eBooks · doi:10.1201/9781420009552 · Cited by 239
Review and analysis of FDA approved drugs using lipid-based formulations
Savla, R., Browne, J., Plassat, V., Wasan, K. M., & Wasan, E. K. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1342654 · Cited by 225
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Hussain, Z., Khan, S., Imran, M., Sohail, M., Shah, S. W. A., & de Matas, M. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00631-4 · Cited by 220
McClements, D. J., & Xiao, H. (2014) · Food Funct. · doi:10.1039/c4fo00100a · Cited by 215
Wong, S. M., Kellaway, I. W., & Murdan, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.001 · Cited by 214
Drug Delivery Nanoparticles Formulation and Characterization
(2016) · CRC Press eBooks · doi:10.3109/9781420078053 · Cited by 205
Italia, J. L., Bhatt, D. K., Bhardwaj, V., Tikoo, K., & Kumar, M. N. V. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.004 · Cited by 203
Intestinal efflux transporters and drug absorption
Murakami, T., & Takano, M. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.923 · Cited by 201
Paediatric formulations—Getting to the heart of the problem
Standing, J. F., & Tuleu, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.006 · Cited by 201
The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles
Mo, R., Jin, X., Li, N., Ju, C., Sun, M., Zhang, C., & Ping, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.005 · Cited by 198
Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps
Werle, M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9347-8 · Cited by 197
Novel lignin nanoparticles for oral drug delivery
Alqahtani, M. S., Alqahtani, A., Al-Thabit, A., Roni, M., & Syed, R. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00594c · Cited by 197
Self-citationDrug metabolism and disposition in children
Strolin Benedetti, M., & Baltes, E. L. (2003) · Fundamental & Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00140.x · Cited by 182
Heparin-loaded zein microsphere film and hemocompatibility
Wang, H.-J., Lin, Z.-X., Liu, X.-M., Sheng, S.-Y., & Wang, J.-Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.014 · Cited by 178
Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations
Shaddy, R. E., Denne, S. C., & The Committee on Drugs and Committee on Pediatric Research (2010) · Pediatrics · doi:10.1542/peds.2010-0082 · Cited by 172
Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability
Sehnert, S. S. (2004) · PubMed Central · Cited by 170
TAKANAGA, H., OHNISHI, A., MATSUO, H., & SAWADA, Y. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.1062 · Cited by 169
Intestinal absorption of water-soluble vitamins: an update
Said, H. M., & Mohammed, Z. M. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000203870.22706.52 · Cited by 168
Transcellular uptake mechanisms of the intestinal epithelial barrier Part one
Daugherty, A. L., & Mrsny, R. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00142-x · Cited by 163
Cheng, L., & Wong, H. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070672 · Cited by 161
Oral transmucosal drug delivery for pediatric use
Lam, J. K. W., Xu, Y., Worsley, A., & Wong, I. C. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.011 · Cited by 160
Intestinal Bile Acid Transport: Biology, Physiology, and Pathophysiology
Shneider, B. L. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07287.x · Cited by 159
Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women
Goldschmiedt, M., Barnett, C. C., Schwarz, B. E., Karnes, W. E., Redfern, J. S., & Feldman, M. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90724-y · Cited by 152
Bachar, M., Mandelbaum, A. D., Portnaya, I., Perlstein, H., Even‐Chen, S., Barenholz, Y., & Danino, D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.004 · Cited by 149
Introduction to Drug Metabolism
Gibson, G. G., & Skett, P. (1986) · Springer eBooks · doi:10.1007/978-1-4899-3188-7 · Cited by 149
Sant, V. P., Smith, D. C., & Leroux, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.010 · Cited by 147
Prodrug Approaches for Enhancing the Bioavailability of Drugs with Low Solubility
Müller, C. E. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900114 · Cited by 146
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
He, C., Yin, L., Tang, C., & Yin, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.033 · Cited by 143
Sachs‐Barrable, K., Thamboo, A., Lee, S. D., & Wasan, K. M. (2007) · PubMed · Cited by 142
Sugano, K., Takata, N., Machida, M., Saitoh, K., & Terada, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00240-5 · Cited by 141
Shapira, A., Davidson, I., Avni, N., Assaraf, Y. G., & Livney, Y. D. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.022 · Cited by 135
Paracellular drug absorption enhancement through tight junction modulation
Lemmer, H. J. R., & Hamman, J. H. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.745509 · Cited by 135
Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review
Greenwald, R. B., Conover, C. D., & Choe, Y. H. (2000) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v17.i2.20 · Cited by 133
Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption
Steffansen, B., Nielsen, C. U., Brodin, B., Eriksson, A. H., Andersen, R., & Frøkjær, S. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.010 · Cited by 132
Polymeric micelles for oral drug administration enabling locoregional and systemic treatments
Simões, S. M. N., Figueiras, A., Veiga, F., Concheiro, Á., & Alvarez‐Lorenzo, C. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.960841 · Cited by 132
In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide
Menzel, C., Holzeisen, T., Laffleur, F., Zaichik, S., Abdulkarim, M., Gumbleton, M., & Bernkop‐Schnürch, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.018 · Cited by 132
Lipophilic prodrugs designed for intestinal lymphatic transport
Charman, W. N., & Porter, C. J. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00105-g · Cited by 124
Polymers for colon specific drug delivery
Schacht, E. H., Gevaert, A., Kenawy, E., Molly, K., Verstraete, W., Adriaensens, P., Carleer, R., & Gelan, J. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00184-0 · Cited by 122
Basit, A. W., Newton, J. M., Short, M. B., Waddington, W. A., Ell, P. J., & Lacey, L. F. (2001) · Pharmaceutical Research · doi:10.1023/a:1010927026837 · Cited by 120
Dahmani, F. Z., Yang, H., Zhou, J., Yao, J., Zhang, T., & Zhang, Q. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.05.015 · Cited by 119
Biomechanics of cell interactions in shear fields
Κωνσταντόπουλος, Κ., Kukreti, S., & McIntire, L. V. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00024-6 · Cited by 118
Gut instincts: CYP3A4 and intestinal drug metabolism
Thummel, K. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34007 · Cited by 117
Is prodrug design an approach to increase water solubility?
Sanches, B. M. A., & Ferreira, E. I. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118498 · Cited by 116
ABC transporters and inhibitors: new targets, new agents.
Leonard, G. D., Polgár, O., & Bates, S. E. (2002) · PubMed · Cited by 115
Liposomal delivery systems for intestinal lymphatic drug transport
Ahn, H., & Park, J. (2016) · Biomaterials Research · doi:10.1186/s40824-016-0083-1 · Cited by 115
Expression, regulation and function of intestinal drug transporters: an update
Müller, J., Keiser, M., Droździk, M., & Oswald, S. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0259 · Cited by 114
Strickley, R. G. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.013 · Cited by 114
Cell uptake and oral absorption of titanium dioxide nanoparticles
Janer, G., del Molino, E. M., Fernández-Rosas, E., Fernández, A. M. C., & Vázquez‐Campos, S. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.04.014 · Cited by 112
Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
de Waard, H., Frijlink, H. W., & Hinrichs, W. L. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0323-3 · Cited by 109
Formation and potential uses of milk proteins as nano delivery vehicles for nutraceuticals: A review
EL‐SALAM, M. H. A., & El‐Shibiny, S. (2011) · International Journal of Dairy Technology · doi:10.1111/j.1471-0307.2011.00737.x · Cited by 108
Planting, A. S. T., Sonneveld, P., van der Gaast, A., Sparreboom, A., van der Burg, M. E. L., Luyten, G. P. M., Leeuw, K. D., de Boer-Dennert, M. M., Wissel, P. S., Jewell, R. C., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0854-6 · Cited by 107
Stabilized micelles as delivery vehicles for paclitaxel
Yoncheva, K., Calleja, P., Agüeros, M., Petrov, P. D., Miladinova, I., Tsvetanov, C. B., & Irache, J. M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.030 · Cited by 106
Juère, E., Florek, J., Bouchoucha, M., Jambhrunkar, S., Wong, K. Y., Popat, A., & Kleitz, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00529 · Cited by 106
Solubility enhancement and application of cyclodextrins in local drug delivery
Kim, D., Lee, S., Pyo, Y.-C., Tran, P., & Park, J. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00434-2 · Cited by 105
Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis
Moulari, B., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.046 · Cited by 103
Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin
Sadekar, S., Thiagarajan, G., Bartlett, K., Hubbard, D., Ray, A., McGill, L. D., & Ghandehari, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.071 · Cited by 100
Yano, K., Masaoka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21919 · Cited by 99
Clinical studies with oral lipid based formulations of poorly soluble compounds.
Fatouros, D. G., Karpf, D. M., Nielsen, F. S., & Müllertz, A. (2007) · PubMed Central · Cited by 98
Han, L., Tang, C., & Yin, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.027 · Cited by 91
Miller, J. M., Dahan, A., Gupta, D., et al. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100050d · Cited by 91
Krishnan, V., Xu, X., Barwe, S. P., Yang, X., Czymmek, K. J., Waldman, S. A., Mason, R. W., Jia, X., & Rajasekaran, A. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300350e · Cited by 86
Onoue, S., Sato, H., Ogawa, K., Kawabata, Y., Mizumoto, T., Yuminoki, K., Hashimoto, N., & Yamada, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.007 · Cited by 85
Choi, J. S., & Jo, B.-W. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.014 · Cited by 77
Lipophilic peptide character – What oral barriers fear the most
Zupančič, O., & Bernkop‐Schnürch, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.038 · Cited by 76
Making medicines that children can take
Nunn, A. J. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.5.369 · Cited by 69
DiMarco, R. L., Hunt, D. R., Dewi, R. E., & Heilshorn, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.023 · Cited by 64
Alqahtani, M. S., Islam, M., Podaralla, S. K., Kaushik, R. S., Reineke, J., Woyengo, T. A., & Perumal, O. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01017 · Cited by 63
Self-citationPharmacokinetics of nanotechnology-based formulations in pediatric populations
Yellepeddi, V., Joseph, A., & Nance, E. A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.008 · Cited by 63
LeCluyse, E. L., & Sutton, S. C. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00434-6 · Cited by 57
Phan, S., Salentinig, S., Prestidge, C. A., & Boyd, B. J. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0168-5 · Cited by 52
Zhang, T., Luo, J., Fu, Y. S., Li, H., Ding, R., Gong, T., & Zhang, Z. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.11.024 · Cited by 51
Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs
Duhem, N., Rolland, J., Riva, R., Guillet, P., Schumers, J., Jérôme, C., Gohy, J., & Véronique Préat, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.010 · Cited by 50
Sosnik, A., Seremeta, K. P., Imperiale, J. C., & Chiappetta, D. A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.655268 · Cited by 50
Liu, X., Huang, H., Wang, J., Wang, C., Wang, M., Zhang, B., & Pan, C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.017 · Cited by 47
Bioadhesive Food Protein Nanoparticles as Pediatric Oral Drug Delivery System
Islam, M. S., Reineke, J., Kaushik, R. S., Woyengo, T. A., Baride, A., Alqahtani, M. S., & Perumal, O. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b00152 · Cited by 47
Self-citationTranscellular and paracellular contribution to transport processes in the colorectal route
Hayashi, M., Tomita, M., & Awazu, S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00072-0 · Cited by 40
Micelles As Delivery System for Cancer Treatment
Keskin, D. S., & Tezcaner, A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170526102757 · Cited by 39
Exploring gastric drug absorption in fasted and fed state rats
Rubbens, J., Mols, R., Brouwers, J., & Augustijns, P. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.017 · Cited by 32
The Pediatric Studies Initiative: After 15 Years Have We Reached the Limits of the Law?
Milne, C., & Davis, J. M. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.11.007 · Cited by 28
Yokooji, T., Mori, N., & Murakami, T. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0010 · Cited by 23
Wang, D., Wang, C., Cao, Y., Zhang, X., Tao, X.-H., Yang, L., Chen, J.-P., Wang, S., & Li, Z. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/547379 · Cited by 20
Cellular membrane trafficking of mesoporous silica nanoparticles
Fang, I., & USDOE Office of Science (SC) (2012) · doi:10.2172/1048532 · Cited by 4
Cited by
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications
Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., Sharma, A., Giri, J., Benival, D., & Kommineni, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041313 · Cited by 628
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Metadata
- Authors
- Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-19
- Volume
- 12
- Pages
- 618411-618411
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3131769770
- Cited by
- 876
- References
- 157
- FWCI
- 43.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.